Ovarian cancer represents one of the most aggressive female tumors worldwide. Over the
decades, the therapeutic options for the treatment of ovarian cancer have been improved …

Background The serum biomarker cancer antigen 125 (CA125) is widely used as an
investigation for possible ovarian cancer in symptomatic women presenting to primary care …

Simple Summary Most women with ovarian cancer are diagnosed after they develop
symptoms—identifying symptomatic women earlier has the potential to improve outcomes …

Background: Over-the-counter (OTC) medications are frequently used to self-care for
nonspecific ovarian cancer symptoms prior to diagnosis. Monitoring such purchases may …

Simple Summary Ovarian cancer is the most common cause of death from gynaecological
cancer in the UK. Survival is better when the disease is diagnosed early. However …

Plasma membrane proteins are a special class of biomolecules present on the cellular
membrane. They provide the transport of ions, small molecules, and water in response to …

Background In the UK, the cancer antigen 125 (CA125) test is recommended as a first-line
investigation in women with symptoms of possible ovarian cancer. Aim To compare time …

Background Missed opportunities for diagnosing cancer cause patients harm and have
been attributed to suboptimal use of tests and referral pathways in primary care. Primary …

Pre-surgical clinical assessment of an adnexal mass is a complex process, and ideally
requires accurate and rapid identification of disease status. Gold standard biomarker CA125 …

Simple Summary Ovarian cancer is the most lethal gynecologic cancer since it is often
diagnosed at advanced stages. Current tools for diagnosis are currently insufficient and …